M&T Bank
TEVA icon

M&T Bank’s Teva Pharmaceuticals TEVA Stock Holding History

M&T Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2
Closed -$1K – 1667
2017
Q2 		$1K Buy
+2
New +$62 ﹤0.01% 1610
2015
Q2 		– Sell
-1,000
Closed -$14K – 2191
2015
Q1 		$14K Hold
1,000
– – ﹤0.01% 1993
2014
Q4 		$10K Hold
1,000
– – ﹤0.01% 2044
2014
Q3 		$7K Buy
+1,000
New +$53K ﹤0.01% 2204

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

M&T Bank's TEVA Position: Q1 2026 in Review

M&T Bank opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2026: 98,463 shares worth $2.97M. The stake represents 0.01% of the portfolio and ranks #500 among its holdings. This is a return to the name: M&T Bank previously reported a position in TEVA as recently as Q3 2019.

M&T Bank first reported a position in TEVA in Q2 2013 and has held it in 27 quarters since. The position peaked at $20.1M in Q1 2015. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • M&T Bank held 98,463 shares of Teva Pharmaceuticals worth $2.97M as of Q1 2026.
  • Teva Pharmaceuticals was a new M&T Bank position in Q1 2026.
  • Teva Pharmaceuticals made up 0.01% of M&T Bank's portfolio in Q1 2026, its #500 holding.
  • M&T Bank first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 27 quarters since.
  • M&T Bank's Teva Pharmaceuticals position peaked at $20.1M in Q1 2015.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.